The Bare Bones: Why the Musculoskeletal System Matters for Safety Assessment

Date

Thursday, October 8, 2020
11:00 AM - 12:00 PM EDT (5:00 PM - 6:00 PM CEST)

Location

Online Webinar
medical illustration of the healthy bone structure

Overview

If you’re developing anti-diabetic or gut hormone-related drugs, serotonin reuptake inhibitors, fibroblast growth agonists, or any other therapeutic targeting elements of the musculoskeletal system, it’s crucial to consider what effects these potential therapeutics can have on the system.

Join our musculoskeletal toxicology experts for this webinar to answer questions on if a drug compound will potentially affect human bones. They will also present pathology and juvenile findings to help you understand the evaluation of bone, muscle, and cartilage in efficacy and safety studies.

 

Webinar Presenters

Aurore Varela Headshot

Aurore Varela, DVM, MSc, DABT
Director, Musculoskeletal Research & Imaging
Charles River


Martin Guillot Headshot

Martin Guillot, DVM, MSc, PhD
Principal Research Scientist, Musculoskeletal Research
Charles River

 
Have a scheduling conflict? Sign up even if you can't make it; we'll share the recording after.
 

We are providing digital education options to keep you learning about topics you may be interested in. For more information, visit criver.com/digital-education.